BMS Enters A Catalyst-Rich Era Full Of Both LOEs And New Launches

2025-2030 Could Bring 10 NMEs, 30 Added Indications

 
• By Mandy Jackson
  
2025 is the start of a six-year period of readouts and launches for BMS (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Leadership